FIELD: chemistry.
SUBSTANCE: compound of Formula (IIb), its stereoisomer or a pharmaceutically acceptable salt.
also relates to a method for preparing a compound of Formula (IIb), a stereoisomer or a pharmaceutically acceptable salt thereof, also relates to the use of a compound of Formula (IIb), a stereoisomer or a pharmaceutically acceptable salt thereof for the manufacture of preparations for the treatment of one or more types of tumors, malignancies, metabolic diseases, autoimmune diseases or disorders associated with RORγt.
EFFECT: ensuring the development of a low molecular weight RORγt agonist having the structure of Formula (IIb).
12 cl, 1 tbl, 122 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AZADECALINS CONDENSED WITH HETEROARYLKETONES - GLUCOCORTICOID RECEPTOR MODULATORS | 2013 |
|
RU2639867C2 |
| SULTAM-BASED COMPOUND AND METHOD OF USE THEREOF | 2017 |
|
RU2741915C2 |
| CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
| SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
| OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | 2014 |
|
RU2674983C1 |
| FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679914C9 |
| N-(AZAARYL)CYCLOLACTAM-1-CARBOXAMIDE DERIVATIVE, ITS PREPARATION METHOD AND ITS APPLICATION | 2018 |
|
RU2765785C2 |
| MONOACYLGLYCEROL LIPASE MODULATORS | 2019 |
|
RU2797323C2 |
| DIAZABENZOFLUORANTHRENE COMPOUNDS | 2016 |
|
RU2697513C2 |
| NOVEL 1,2-BIS-SULPHONAMIDE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR | 2011 |
|
RU2654213C9 |
